Table 3 The percentages of relative cytochrome P450 gene expression in THLE-3 after treatments at the concentration of 50 µg/mL for 48 h, normalized by β-actin.
Condition | % Relative gene expression | ||||
---|---|---|---|---|---|
CYP1A2 | CYP2A6 | CYP3A4 | CYP2D6 | CYP2E1 | |
DMSO | 100.00 ± 0.00a | 100.00 ± 0.00a | 100.00 ± 0.00a | 100.00 ± 0.00a | 100.00 ± 0.00a |
B. cristata | 74.54 ± 0.70b | 103.24 ± 0.53a | 87.80 ± 2.10a | 46.29 ± 1.56b | 70.72 ± 4.67b |
B. siamensis | 59.19 ± 0.67b | 72.00 ± 0.72b | 46.63 ± 0.65b | 27.75 ± 0.59b | 59.96 ± 0.88b |
B. strigosa | 119.53 ± 0.89a | 133.75 ± 2.80b | 103.10 ± 0.75a | 77.29 ± 0.74b | 158.81 ± 2.43b |
Barlerin | 94.69 ± 0.96a | 102.45 ± 1.51a | 81.01 ± 3.94a | 54.07 ± 2.94b | 116.22 ± 1.75a |
Verbascoside | 82.23 ± 0.87a | 90.14 ± 2.65a | 82.87 ± 0.75a | 38.38 ± 1.74b | 84.63 ± 4.46a |